Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Biotest, Abbott partner to develop and commercialize BT-061 for autoimmune diseases

Abbott and Biotest AG today announced a global agreement to develop and commercialize BT-061, a novel anti-CD4 antibody for the treatment of rheumatoid arthritis (RA) and psoriasis.

22 Jun 2011

HSS orthopedic surgeon earns recognition for research on metabolic bone disease

Joseph M. Lane, M.D., an orthopedic surgeon nationally recognized for his work in metabolic bone disease, will receive the Lifetime Achievement Award at the hospital's 28th Annual Tribute Dinner on Monday, June 20, for his innovative research on bone disease and the use of bisphosphonates in treating osteoporosis. Brian Williams, anchor of Nightly News on NBC, will serve as toastmaster.

21 Jun 2011

Initiation of ALD518/BMS-945429 Phase 2b clinical trial in RA triggers milestone payment to Alder

Alder Biopharmaceuticals Inc. today announced it will receive a $15 million milestone payment from Bristol-Myers Squibb for the initiation of a Phase 2b clinical trial in rheumatoid arthritis for ALD518/BMS-945429, an investigational antibody therapeutic that blocks interleukin-6 (IL-6).

20 Jun 2011

Endocrine Society honors BUSM professor with The Delbert A. Fisher Research Scholar Award

Michael F. Holick, PhD, MD, director of the General Clinical Research Center and professor of medicine, physiology and biophysics at Boston University School of Medicine, is this year's recipient of The Delbert A. Fisher Research Scholar Award from the Endocrine Society for his scholarly work on the history of endocrinology.

18 Jun 2011

NASDAQ halts Regeneron's common stock

Regeneron Pharmaceuticals, Inc. announced that NASDAQ has halted trading of the company's common stock.

17 Jun 2011

HHS announces funding opportunity for national networks of community-based organizations

The U.S. Department of Health and Human Services (HHS) today announced a funding opportunity for national networks of community-based organizations to apply for more than $4 million in cooperative agreements.

17 Jun 2011

Positive results from etanercept pilot study against dermatomyositis

A multicenter pilot study of etanercept for treatment of dermatomyositis found no major safety concerns and many patients treated with the drug were successfully weaned from steroid therapy.

17 Jun 2011

$Economic burden of fractures in Europe has been vastly underestimated: New report$

Economic burden of fractures in Europe has been vastly underestimated: New report

A new report launched today by the International Osteoporosis Foundation (IOF) in collaboration with the European Federation of Pharmaceutical Industry Associations (EFPIA) reveals that the burden of fractures in Europe has been vastly underestimated.

16 Jun 2011

ClinTec opens fully registered offices in China, Singapore and Thailand for clinical research

UK based Global Clinical Research Organisation (CRO), ClinTec International has continued its international expansion by opening fully registered offices in China, Singapore and Thailand - consolidating its presence in the Asia Pacific region.

16 Jun 2011

Children's Medical Center to open new $21M Specialty Care Center in Southlake

Children's Medical Center will debut its new Specialty Care Center in Southlake on June 18, a $21 million expansion which will serve children in one of the state's fastest-growing cities and the surrounding communities.

16 Jun 2011

Magnesium essential for absorption and metabolism of vitamin D and calcium

Magnesium deficiency is an important factor in the results obtained from vitamin D. According to Dr. Carolyn Dean, MD, ND, magnesium expert and Medical Director of the nonprofit Nutritional Magnesium Association, the effectiveness and benefits of vitamin D are greatly undermined in the absence of adequate levels of magnesium in the body.

15 Jun 2011

NYU Langone implements biometric technology to identify patients

NYU Langone Medical Center announced today that it is the first medical center in the Northeast to use PatientSecure™ - a cutting-edge biometric technology - to identify patients. Utilizing near infrared light to map an image of the blood-flow pattern through the veins in a person's palm, the digital palm image is converted into a unique patient identifier that interfaces with the medical center's electronic health record system.

15 Jun 2011

Wnt signaling may help target hair pigmentation

A new study by researchers at NYU Langone Medical Center has shown that, for the first time, Wnt signaling, already known to control many biological processes, between hair follicles and melanocyte stem cells can dictate hair pigmentation. The study was published in the June 11, 2011 issue of the journal Cell.

15 Jun 2011

Jamieson introduces UC-II undenatured collagen to relieve osteoarthritis pain

Most people think that arthritis is an inevitable part of aging. Today, Jamieson Laboratories has introduced UC-II undenatured collagen, a formulation that will turn back the clock on joint pain by naturally promoting the restoration of cartilage and inhibiting its deterioration. This new anti-aging formula taken only once daily is proven to be twice as effective as other joint remedies.

15 Jun 2011

Research reveals how humans of different ancestry process polyunsaturated fat

Over the past decade, much progress has been made regarding the understanding and promise of personalized medicine. Scientists are just beginning to consider the impact of gene-diet interactions in different populations in regards to disease prevention and treatment.

15 Jun 2011

Humira defect lawyers file suit against Abbott Laboratories in federal court

Humira defect lawyers filed a lawsuit against Abbott Laboratories in federal court today claiming Abbott's blockbuster drug, Humira, caused a fungal infection resulting in the near-death of a Tennessee man.

14 Jun 2011

Nose spray vaccine for type 1 diabetes could be a reality soon

Melbourne researchers are nearing the development of a vaccine for type 1 diabetes, after showing that a nasal spray can stop the body's immune system from attacking insulin-producing cells.

13 Jun 2011

CEL-SCI initiates Multikine Phase III clinical trial for head and neck cancer in Hungary

CEL-SCI Corporation announced today that it has commenced its Phase III clinical trial for Multikine®, the Company's flagship immunotherapy, at the National Institute of Oncology in Budapest, Hungary. Enrollment is expected to start soon in this center. The study is already ongoing at twelve clinical sites in the United States, Canada, Poland and India.

13 Jun 2011

Scientists identify potential target for reversing deadly blood infection sepsis

By digging a little deeper, researchers may have found a potential target for reversing the deadly blood infection sepsis.

13 Jun 2011

Hanwha, Merck partner to develop and commercialize HD203

Merck, known as MSD outside the United States and Canada, and Hanwha Chemical Corporation today announced that they have entered into an exclusive global agreement to develop and commercialize a candidate biosimilar form of Enbrel.

13 Jun 2011

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Biotest, Abbott partner to develop and commercialize BT-061 for autoimmune diseases

HSS orthopedic surgeon earns recognition for research on metabolic bone disease

Initiation of ALD518/BMS-945429 Phase 2b clinical trial in RA triggers milestone payment to Alder

Endocrine Society honors BUSM professor with The Delbert A. Fisher Research Scholar Award

NASDAQ halts Regeneron's common stock

HHS announces funding opportunity for national networks of community-based organizations

Positive results from etanercept pilot study against dermatomyositis

Economic burden of fractures in Europe has been vastly underestimated: New report

ClinTec opens fully registered offices in China, Singapore and Thailand for clinical research

Children's Medical Center to open new $21M Specialty Care Center in Southlake

Magnesium essential for absorption and metabolism of vitamin D and calcium

NYU Langone implements biometric technology to identify patients

Wnt signaling may help target hair pigmentation

Jamieson introduces UC-II undenatured collagen to relieve osteoarthritis pain

Research reveals how humans of different ancestry process polyunsaturated fat

Humira defect lawyers file suit against Abbott Laboratories in federal court

Nose spray vaccine for type 1 diabetes could be a reality soon

CEL-SCI initiates Multikine Phase III clinical trial for head and neck cancer in Hungary

Scientists identify potential target for reversing deadly blood infection sepsis

Hanwha, Merck partner to develop and commercialize HD203

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in